Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Other financing activities (2017 - 2024)

Ekso Bionics Holdings (EKSO) has disclosed Other financing activities for 5 consecutive years, with $1000.0 as the latest value for Q2 2024.

  • On a quarterly basis, Other financing activities changed 0.0% to $1000.0 in Q2 2024 year-over-year; TTM through Mar 2025 was $1000.0, a 100.58% increase, with the full-year FY2024 number at $1000.0, changed N/A from a year prior.
  • Other financing activities was $1000.0 for Q2 2024 at Ekso Bionics Holdings, roughly flat from $1000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1000.0 in Q2 2023 to a low of $1000.0 in Q2 2023.